Re: investing in sabatoge

[James Love <love@cptech.org>]

A Univeristy of California researcher claims Amgen did not want to use a
technology that would reduce by half the dose of EPO patients need.
jamie


On Sat, 29 May 1999, Michael Perelman wrote:

> I am interested in learning about examples of corporations investing in
> technologies to restrict the usefulness of their products.  Monsanto's
> terminator technology, for example, makes seeds less useful to farmers.
> I recall that IBM added circuitry to its PC Jr. to make it difficult to
> install a second hard time.  Microsoft is accused of similar mischief.
> --
> Michael Perelman
> Economics Department
> California State University
> Chico, CA 95929
> 
> Tel. 530-898-5321
> E-Mail michael@ecst.csuchico.edu
> 
> 
> 

-------------------------------
James Love 
Center for Study of Responsive Law | Consumer Project on Technology 
P.O. Box 19367, Washington, DC 20036 | http://www.cptech.org
Voice 202/387-8030 | Fax 202/234-5176 | love@cptech.org